Search

everythinglearnresearchcommunity

for

Search:↓

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Certain genetic variations can make people more likely to experience hair loss and low white blood cell count from azathioprine.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

The niosomes effectively target hair follicles for acne treatment.

Hormonal contraceptives may reduce social behavior and sexual motivation by lowering allopregnanolone levels.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Abrocitinib may effectively treat Lichen Planopilaris.

Choose treatments for sex offenders based on individual needs, using hormonal and nonhormonal options to reduce sexual drive.

The NUDT15 gene variant causes severe side effects from azathioprine in some Indian patients.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

High-dose methotrexate can cause severe skin and nail issues.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

New drug uses show promise but need more research.

Paroxetine relieves pain by increasing allopregnanolone levels.

Allopregnanolone can reduce gut inflammation and normalize neurotransmitter levels after finasteride withdrawal.

Recreational drug use can cause misdiagnosed conditions and drug interactions in HIV patients.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Morphine increases testosterone breakdown in the rat brain and spinal cord.

Leuprolide effectively reduces hair growth in hirsute women at higher doses.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Methotrexate plus prednisolone had the fewest serious side effects.

Upadacitinib improved multiple immune-related conditions in one patient.